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Abstract
Hybrid cells created by fusion of antigen presenting and tumour cells have been shown to induce potent protective and
curative anti-tumour immunity in rodent cancer models. The application of hybrid cell vaccines for human tumour therapy
and the timely intervention in disease control are limited by the requirement to derive sufficient autologous cells to preserve
homologous tumour antigen presentation. In this study, the efficiency of various methods of electrofusion in generating
hybrid human cells have been investigated with a variety of human haemopoietic, breast and prostate cell lines. Cell fusion
using an electrical pulse is enhanced by a variety of stimuli to align cells electrically or bring cells into contact. Centrifugation
of cells after an exponential pulse from a Gene Pulser electroporation apparatus provided the highest yield of mixed cell
hybrids by FACS analysis. An extensive fusogenic condition generated in human cells after an electrical pulse contradicts the
presumption that prior cell contact is necessary for cell fusion. Alignment of cells in a concurrent direct current charge and
osmotic expansion of cells in polyethylene glycol also generated high levels of cell fusion. Waxing of one electrode of the
electroporation cuvette served to polarise the fusion chamber and increase cell fusion 5-fold. Optimisation of a direct current
charge in combination with a fusogenic pulse in which fusion of a range of human cells approached or exceeded 30% of the
total pulsed cells. The yield of hybrid prostate and breast cancer cells with dendritic cells was similar to the homologous cell
fusion efficiencies indicating that dendritic cells were highly amenable to fusion with human tumour cells under similar
electrical parameters. Elimination of unfused cells by density gradient and culture is possible to further increase the quantity
of hybrid cells. The generation and purification of quantities of hybrid cells sufficient for human vaccination raises the
possibility of rapid, autologous tumour antigen presenting vaccines for trial with common human tumours. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Many tumours express distinct antigens which can
be targeted in vaccine strategies aimed at promoting
immunological defense mechanisms [1^3]. The dem-
onstration that human malignancies carry speci¢c
antigens, and the rejection of tumour cells in both
animal models and humans, has set the stage for a
new generation of cancer vaccines for promoting a
curative immune response to tumours.
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Tumour cells infrequently invoke a spontaneous
immune response. Immunotherapy approaches have
therefore attempted to increase the immunogenicity
of transformed cells. However, the heterogeneity and
unpredictability of immune function defects in hu-
man tumour precludes a single gene modi¢cation
strategy for human cancer. Reduced or absent class
I major histocompatability complex (MHC) expres-
sion is frequently observed in malignant cells of dif-
ferent origin [4,5], indicating that disrupted antigen
presentation is a common means of immunological
escape. Loss of the antigen transporting proteins
TAP-1 and -2, required for stable MHC class I sur-
face expression, correlates highly with MHC loss [6^
8]. Interference with co-stimulatory molecule expres-
sion, required in combination with MHC antigen
presentation, is indicated by the success of vaccina-
tion with B7 gene transfected tumour cells [9,10]. An
absence of co-stimulatory molecules might induce a
negative signal resulting in T-cell anergy to tumour
antigens. Additionally, defective expression of LMP
genes, associated with antigen processing, have been
detected in malignancy [11]. One study of cell lines
established from prostate cancers showed that all
lines examined were dysfunctional by quite di¡erent
mechanisms [12].
An attractive strategy that circumvents these di⁄-
culties is the use of a whole-cell vaccine composed of
antigen presenting cells fused with the tumour cells
[13^15]. Such cells would both express speci¢c tu-
mour antigens and possess intact immunological
molecules for antigen presentation and T-cell activa-
tion. Dendritic cells are bone marrow derived leuko-
cytes whose capacity for stimulation of the immune
system through T-cell-mediated responses are the
most e¡ective of all known antigen-presenting cells
(APCs) [16]. They possess an abundance of both
classes of MHC molecules and present antigen for
a prolonged period [17] accompanied by a range of
costimulatory and adhesive accessory signals, includ-
ing B7-1, B7-2, ICAM-1, ICAM-3, CD-40 [18]. The
ability of highly motile dendritic cells to transport
antigen to lymph nodes and activate e¡ector T-cells
has led to their proposal as the ideal candidate for
the induction of speci¢c anti-tumour immunity
[19,20].
Dendritic cells transduced with tumour antigen
RNA can induce speci¢c cytotoxic T-lymphocytes
in vivo [21]. Dendritic cells pulsed with antigen [22]
or expressing antigen from adenovirus or retrovirus
viral vectors [23,24], confer potent protection against
lethal tumour challenge in animal models. Hybrid
cell vaccines produced by fusion of murine dendritic
cells with colon adenocarcinoma cells [13] or B-lym-
phocytes or lymphocyte-derived cell lines fused with
rat hepatocarcinoma cells [14] or myeloma cells [15]
not only induced strong protection to tumour chal-
lenge but, most signi¢cantly in terms of human ther-
apy, promoted the immunological rejection of estab-
lished tumours in almost all animals.
The demonstration of protective murine responses
to tumour fusion hybrids have utilised polyethylene
glycol techniques developed for creating monoclonal
antibody hybridomas [25]. Cell lines established from
mouse antigen-presenting cells fused with syngeneic
tumour cells were cultured to su⁄cient quantities.
The di⁄culty in generating e⁄cient cell fusion to
prepare su⁄cient quantities of hybrid, tumour-anti-
gen-presenting cells without culture imposes a limi-
tation in the furtherance of hybrid cell vaccines for
autologous treatment of human cancers. Human vac-
cination will require a much more rapid and e⁄cient
procedure to achieve intervention at a therapeutic
level before signi¢cant disease progression. We have
explored the potential of a range of electrofusion
protocols with the aim of preparing su⁄cient hybrid
cells to serve as an immediate autologous vaccine.
Optimal conditions for simultaneous fusion of
many APCs and cancer cells have been derived which
should make hybrid cellular vaccines for cancer ther-
apy feasible. This data should contribute to the rapid
generation of autologous vaccines for treatment of
cancer in human trials.
2. Materials and methods
Cell lines PC-3 and LNCaP (metastatic bone and
lymph node derived human prostate adenocarcinoma
cells, American Type Culture Collection (ATCC),
Rockville, MD, USA; CRL-1435 and CRL-1740),
293 (adenovirus-transformed human embryonic kid-
ney; ATCC 45504), and human breast adenocarcino-
ma cells MDA-MB-231 and MCF-7 (ATCC HTB-23
and HTB-22) were grown in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% foetal bo-
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vine serum (FBS), 100 U/ml penicillin, 100 mg/ml
streptomycin and 2 mM L-glutamine (Sigma-Aldrich,
Poole, Dorset). H9 and K562 (ATCC HTB-176 and
CCL-243) cells were grown in RPMI 1640 medium
supplemented with 10% FBS and the same additives.
Dendritic cells were prepared by culture of CD34+
progenitor cells in a cytokine-supplemented medium.
Haematopoietic progenitor cells were isolated by
positive selection of CD34-expressing cells from
cord blood using a MiniMACS CD34 Progenitor
Cell Isolation Kit (Miltenyi Biotec). Cord blood, 50
ml collected in 10 ml Iscove’s modi¢ed Eagle’s me-
dium containing 2 U/ml heparin (IMDM/heparin),
was diluted 1:2 with phosphate-bu¡ered saline
(PBS) containing 0.6% citrate dextrose formula A
(ACD-A, Baxter) and 0.5% bovine serum albumin
(BSA, Difco). Mononuclear cells were obtained by
density gradient centrifugation over 0.5 vols. of His-
topaque 1077 (Sigma-Aldrich) centrifuged for 30 min
at 400Ug at 20‡C. Cells banded at the interphase
were collected and washed twice with 40 ml
IMDM/heparin and viable cells counted after resus-
pension in PBS containing 3% acetic acid. Cells were
then pelleted (200Ug for 10 min) and resuspended in
cold IMDM/heparin at a concentration of 300 Wl per
108 mononuclear cells and treated with MiniMACS
reagents as recommended by Miltenyi Biotec. Eluted
CD34+ cells were then cultured at 5U105 cells/ml for
5 days in IMDM supplemented with 20% FCS, 100
U/ml penicillin, 100 mg/ml streptomycin and 2 mM
L-glutamine, 100 ng/ml recombinant human granulo-
cyte-macrophage colony stimulating factor (GM-
CSF; RpD Systems), 20 ng/ml recombinant human
interleukin 4 (IL-4; RpD Systems) and 20 ng/ml
recombinant human Flt3/Flk2 ligand (RpD Sys-
tems), a procedure that resulted in s 95% MHC
class II expressing cells as assessed by FACS analy-
sis. Cells were harvested for electrofusion by after
gentle pipetting, leaving tightly adherent cells.
2.1. Staining of cells
CellTracker Probes (Molecular Probes, Oregon,
USA) 5-chloromethyl £uorescein diacetate
(CMFDA) and 5- and 6-chloromethyl benzoyl amino
tetramethylrhodamine (CMTMR) were supplied by
Cambridge Bioscience and stored at 380‡C as 10-
mM stock solutions in dimethyl sulphoxide. These
dyes, containing thiol-reactive chloromethyl groups,
freely di¡use through cell membrane and interact
with cytoplasmic glutathione transferases, forming
impermeable £uorescent thioether adducts which
prevents the leakage and transfer between cells
[26,27]. To determine the optimum staining condi-
tions, cells at a density of 107/ml were stained with
a range of dye concentrations in growth medium for
30 min in the dark, washed twice in Hank’s balanced
salt solution (HBSS), replaced in the appropriate
growth medium and examined by FACS analysis
after various periods of incubation. Stained cells re-
suspended in fresh medium maintained £uorescent
intensity and the same multiplication rate as un-
stained cells through at least four cell divisions.
Moreover, cells stained with either CMFDA or
CMTMR and incubated together for 24 h or more
remained devisable into two populations with exclu-
sive red or green £uorescence. The minimum concen-
trations (0.25 WM CMFDA and 4.5 WM CMTMR)
of stains resulting in a log or greater di¡erence in
£uorescent intensity between stained and unstained
cells with all human cells were examined (data not
shown). It was found that the £uorescent intensity
was altered by an electrical charge given within 2
or 3 h of staining. Adherent cells were therefore re-
plated in growth medium for 24 h after staining and
retrypsinised prior to an experiment.
2.2. Electrofusion
For each fusion, equal numbers of cells were
stained with CMFDA and with CMTMR. Cells
were harvested the day following staining, washed
twice in HBSS, viable numbers determined and cell
density adjusted to 1.5U106 cells/ml in an isotonic
solution of sucrose/NaCl passed through a 0.2-Wm
¢lter. Isotonic 0.3 M sucrose was used as the medium
for cells during fusion unless otherwise stated. Mo-
lecular equivalents to formulate an isotonic solution
with di¡ering proportions of sucrose and NaCl were
established from Bergey’s manual of chemical solu-
tions. Electrofusion was performed with an equal
proportion of mixed red and green £uorescent cells
at a total of 1U106 cells per 0.75 ml in an electro-
plated cuvette (Bio-Rad). Inert wax (Difco Polywax
8829-19, melting temperature 57‡C) was applied to
one electrode of the cuvette by pipetting 150 Wl of
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liquid wax into a horizontally held, heated cuvette.
Alternatively, a special chamber was made to test the
e¡ect of centrifugation onto the basal electrode. A
cone in a 4U1.5 cm cylinder of perspex [28] was
capped with copper electrodes at base and apex,
the upper electrode rotating on a thread to form a
chamber of adjustable size for delivery of the pulse to
cells pellet in line parallel to the direction of the
pulse.
Cells were ¢rst aligned by means of direct or alter-
nating electrical current supplied for 5 s prior to
electrofusion. Electrofusion was driven by a Cober
605 pulse generator or a Bio-Rad Gene Pulser, deliv-
ering square or exponential pulses, respectively, con-
nected to the power supply via an intervening Sum-
mation Box containing two diodes to prevent
feedback, as depicted in Fig. 1. The cuvette or cham-
ber was left to stand for at least 5 min before cells
were removed in a series of HBSS rinses. The total
viable cell yield was established from the count of
cells in an aliquot mixed with an equal volume of
0.4% trypan blue using a haemocytometer. Cells
were than deposited by centrifugation at 3000 rpm
for 5 min in a microfuge tube, ¢xed in 500Wl of PBS
containing 1% paraformaldehyde and analysed by
£ow cytometry (Becton Dickinson FACScan) with
CellQuest software. Fused cell hybrids were largely
discernible in forward vs side scatter plots as a pock-
et of larger and less refractile cells. The proportion of
hybrids was enumerated in FL1 (green £uorescence)
vs FL2 (red £uorescence) dot plots so that only hy-
brids of dual £uorescence were counted. Dead cells
were excluded from the gate so as not to appear in
the evaluation of % fusion and the number of dual
£uorescent hybrids was calculated by multiplication
with the proportion of live cells recovered, evaluated
by trypan blue exclusion in a haemocytometer. Fluo-
rescent microscopy examination of cells fused in dif-
ferent combinations showed an approximately equal
tendency of cells to fuse with each other, with all
green and all red hybrid cells approximating the
numbers of red-green hybrid cells (data not shown).
2.3. Puri¢cation and ampli¢cation of hybrid cells
Density gradients composed of 6 ml of Poly-
morphprep (Nycomed, Birmingham) overlaid with
6 ml of 106 pulsed cell suspension in a 15-ml conical
tube were centrifuged for 15 min at 500Ug. Hybrid
cells, exhibiting dual £uorescence in FACS analysis
appeared as a non-discrete, but distinct band below
that of single cells. Increasing the concentration of
dextran 500 to 10% w/v and centrifugation for a
lesser time both served to increase the separation of
the bands. Pooling the hybrid cell bands and re-
peated density gradient centrifugation reduced the
yield of single stained cells. Hybrid cells, pelleted
twice in PBS, were cultured in IMDM with 20%
FBS in 25 cm2 £asks. Approximately half the cells
were examined by FACS every 5 days.
3. Results
3.1. Examination of electrical parameters
The e¡ect of applying an electrical charge of alter-
nating or direct current (DC) on the integrity and
permeability of cellular membranes was investigated
with trypan blue dye. An alternating charge of
1 MHz applied to PC-3 cells in a cuvette at 100^
200 V per cm destabilised the membrane within 5 s,
allowing temporary entry of trypan blue in greater
Fig. 1. Electrical circuitry. A power source, supplying a con-
stant DC charge to force cells into proximity, is arranged in
parallel with a Bio-Rad Gene Pulser. A summation box directs
the pulse and DC charge to the cuvette and prevents feedback.
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than 50% of cells relative to the duration of the
charge. Almost all stained cells charged with alter-
nating current at these voltages were able to expel
the dye within 30 min, indicating a temporary desta-
bilisation of the membrane. Application of a direct
current of greater than 50 V per cm for longer than
5 s did adversely a¡ect the survival of cells.
In trials, application of DC current of 12.5 to 100
V per cm to cells in a cuvette for 5 s prior to delivery
of a pulse of 100 V/800 6/25 WFd by the Gene Pulser
augmented the fusion rate several fold. Alternating
current up 200 V/cm at 1 MHz applied to cells in the
cuvette for 5 s prior to the electrical pulse did not
signi¢cantly increase fusion of cells, despite an in-
crease in trypan blue-permeability. Therefore a com-
bination of DC current and a fusogenic pulse was
used to drive cellular fusion as shown in Fig. 1. A
laboratory power supply, delivering a constant DC
current, to compel cell contact prior to a fusogenic
charge, is arranged in parallel to the Gene Pulser
with an intervening summation box containing di-
odes to prevent feedback.
3.2. Examination of cell conductivity
Factors a¡ecting the duration of the electrical
charge, measured by the Gene Pulser as the time to
release 50% of the exponential pulse, were varied as
detailed in Fig. 2. The distance between plates of the
cuvette, the conductivity of the solution determined
by the concentration of salt in the isotonic cell me-
dium and the application of an insulating wax ap-
plied to one electrode of the cuvette all modulated
the conductivity. Waxing of the cuvette dramatically
increased the pulse duration and the survival of the
pulsed cells. Application of direct current to the cu-
vette for 5 s prior to the pulse brought a large in-
crease in the proportion of hybrid cells without sub-
stantially a¡ecting cell survival. Addition of salt
increased the percentage of fused cells proportional-
ly, but also the severity of the condition, reducing the
survival of pulsed cells. The overall production of
hybrid cells was proportional to the pulse delivery
time and became optimal between 15 and 20 ms.
3.3. Electrofusion of human cell lines
Electrofusion was performed over a range of elec-
trical conditions using two prostate cancer cell lines
and two breast cancer cell lines with variations in the
DC current (VDC) and voltage (V), resistance (6)
and capacitance (WFd) parameters of the Gene Pulser
or voltage and pulse duration with the Pulse Gener-
ator. The e¡ect on fusion e⁄ciencies is portrayed in a
typical sample of conditions from reproducible ex-
periments with LNCaP, PC-3, MCF-7 and MDA-
MB-231 cells in Fig. 3. The percentage of dual-£uo-
rescent hybrid cells is enumerated in the upper right
quadrant of each plot. FACS analysis of the pulsed
cells counted only the mixed cell hybrids. Fluorescent
microscopy demonstrated that the proportion of bi-
nucleate red hybrids and green hybrids was similar to
the FACS enumeration of dual £uorescence hybrids
or % fusion.
Each cell line behaved slightly di¡erently under the
variations in charge. The proportion of hybrid MDA
Fig. 2. E¡ect of pulse time. The conductivity of the cell was
modulated with the addition of salt to the cell medium, varying
the distance between plates of the cuvette, and by application
of wax to the cathode. The percentage of fused cells was mea-
sured as dual £uorescent hybrid cells in £uorescent activated
cell sorting and the yield of live cells de¢ned by trypan blue ex-
clusion in a haemocytometer. The production of hybrid cells in-
creased with the pulse delivery time and reached a maximum
between 15 and 20 ms.
BBADIS 61908 16-2-00
T.H. Scott-Taylor et al. / Biochimica et Biophysica Acta 1500 (2000) 265^279 269
BBADIS 61908 16-2-00
T.H. Scott-Taylor et al. / Biochimica et Biophysica Acta 1500 (2000) 265^279270
MB 231 and MCF-7 cells rose moderately with in-
creasing voltage of the pulse, whereas the proportion
of hybrid LNCaP cells doubled between 100 and 250
V, but fell precipitously at 300 V. Fusion of PC-3
cells was adversely a¡ected by higher voltages, peak-
ing at 200 V of the Gene Pulser. Variation of the
resistance of the pulse had little e¡ect on fusion of
these cell lines, but increase in the capacitance mod-
erately improved percentage of hybrids of LNCaP
and more than doubled the proportion of hybrid
MDA MB 231 cells. Cumulative voltages of the
DC and Gene Pulser charges could adversely a¡ect
the cells and these parameters were more closely ex-
amined in combination. The percentage fusion, cell
survival and the overall yield of hybrid PC-3 and 293
cells under increasing DC charge is shown at three
Gene Pulser voltages in Table 1. As might be ex-
pected, the Gene Pulser and DC supply voltages
are additive, contributing to a fusion rate that can
be optimised by inversely varying the two charges.
At the higher Gene Pulser voltages, better fusion
rates are achieved with the lower DC charge. The
DC charge contributed to cell mortality and in com-
bination with higher Gene Pulser voltages signi¢-
cantly reduced yield of hybrid cells.
3.4. Alternative methods for cell alignment
A variety of conditions utilising polyethylene gly-
col and/or centrifugation to force cell contact or
align cells in close proximity before or after applica-
tion of a DC pulse were examined as detailed in
Table 2. Application of a DC current for 5 s prior
to an exponential pulse was shown to moderately
reduce cell survival, but improve cell fusion 5-fold,
resulting in a 3.7-fold increase in hybrid cell yield.
Relevant to the demonstration in the dielectrophore-
sis model of electrofusion [29] that maximal hybrid
formation is not achieved till the third or fourth
pulse, the e¡ect of multiple pulses were examined.
After three pulses, the fusion rate was not improved
in our conditions and the cell survival was reduced
by a third. A square pulse, of constant charge for a
speci¢c period, was compared to the exponential
pulse delivered by the Gene Pulser in comparative
media with the 4-mm cuvette. Increasing the ampli-
tude of the square pulse between 125 and 500 V per
cm (conditions 5^7), parameters that have been suc-
cessful in dielectrophoresis model of cell fusion, did
induce cell fusion, but to a lesser degree than the
levels achieved with the exponential pulse. DC align-
Table 1
E¡ect of the magnitude of DC charge on fusion of human cells
DC (VDC) Pulser (V) PC-3 cells 293 cells
% Hybrids % Survival Yield (U103) % Hybrids % Survival Yield (U103)
15 200 5.2 62.3 40.6 12.6 66.6 125.9
30 200 5.8 46.6 48.9 17.5 61.4 161.2
60 200 5.9 53.3 47.2 18.2 54.9 149.9
75 200 4.2 24.7 21.0 11.4 32.5 55.6
15 250 7.6 60.0 68.4 ND
30 250 10.8 53.3 86.4 ND
60 250 5.5 33.3 27.5 ND
75 250 3.4 37.3 21.8 ND
15 300 ND 13.7 61.8 126.9
30 300 ND 9.6 53.3 76.8
60 300 ND 6.7 43.9 44.2
75 300 ND 6.9 32.6 33.7
Capacitance and resistance were maintained at 25 WFd and 800 6. Live cells were counted in trypan blue and multiplied by % dual
£uorescent hybrids to calculate total hybrid yield per condition. ND, not done.
6
Fig. 3. Electrofusion of human cell lines. FL1 (green £uorescence) versus FL2 (red £uorescence) dot plots of PC-3, LNCaP, MDA
MB 231 and MCF-7 cells, charged with di¡erent electrical parameters in waxed 4-mm cuvettes, are shown with the percentage of
events in the upper right quadrant enumerated by CellQuest software statistics.
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ment in combination with a square pulse doubled the
proportion of hybrid cells in a waxed cuvette (con-
dition 6 vs 4). No improvement of fusion was
achieved by square pulses of higher voltages (condi-
tion 7). Increasing the pulse duration from 5 to 30 Ws
(conditions 8^10) had little e¡ect on cell survival, but
did not correlate with the rate of cell fusion.
The e¡ect of alignment of cells relative to the £ow
of current was observed with a specially constructed
centrifugation chamber with a copper electrode base
onto which the cells could be deposited. Centrifuga-
tion prior to the pulse in the cuvette (condition 11),
depositing cells in a pellet perpendicular to the direc-
tion of the current, did not induce cell fusion much
above the basal level of the pulse with suspended
cells (condition 1). Pulsing of cells pelleted on the
basal electrode of the chamber, parallel to the £ow
of current, produced almost four times the propor-
tion of fusion as the cells pelleted in the cuvette (con-
dition 14 vs 11). Deposition of the cells immediately
following the pulse (condition 12) was more success-
ful that prior to the pulse and when combined with
prior DC alignment induced the highest rate of hy-
brid cell yield of any condition observed (condition
15).
Polyethylene glycol (PEG) added to the isotonic
Table 2
Alternative methods for cell alignment
No. DC
chargea
Medium
PEG (v/%)b
Cell Pulse type
(V/Ws)
Centrifugationc % Hybrid % Survival Hybrid yieldU103
1 3 ^ Cuvette Exp ^ 2.6 86.4 22.5
2 + ^ Cuvette Exp ^ 13.2 63.0 83.2
3 + ^ Cuvette Exp U3 ^ 11.4 45.7 52.1
4 3 ^ Cuvette Sq (250/15) ^ 4.1 45.8 18.8
5 + ^ Cuvette Sq (125/15) ^ 5.2 79.5 41.3
6 + ^ Cuvette Sq (250/15) ^ 8.4 58.3 49.0
7 + ^ Cuvette Sq (500/15) ^ 6.5 21.1 13.7
8 + ^ Cuvette Sq (250/5) ^ 9.6 57.8 55.5
9 + ^ Cuvette Sq (250/10) ^ 4.3 47.2 20.3
10 + ^ Cuvette Sq (250/30) ^ 5.7 63.0 35.9
11 3 ^ Cuvette Exp Prior 3.6 70.2 25.3
12 3 ^ Cuvette Exp Post 11.9 32.0 38.1
13 3 ^ Cuvette Exp Prior and post 6.5 3.0 2.0
14 + ^ Chamber Exp Prior 13.6 42.1 57.3
15 + ^ Chamber Exp Post 15.1 62.7 94.7
16 + ^ Chamber Exp Prior and post 2.9 64.6 18.7
17 + 10 Cuvette Exp ^ 10.7 25.3 27.1
18 3 10 Cuvette Exp ^ 5.8 51.8 30.0
19 3 10 Cuvette Exp U3 ^ 6.8 33.4 22.7
20 3 20 Cuvette Exp ^ 7.7 51.4 39.6
21 3 40 Cuvette Exp ^ 9.2 39.6 36.4
22 3 10 Cuvette Exp Post 5.9 30.5 17.9
23 3 20 Cuvette Exp Post 5.2 28.4 14.9
24 3 40 Cuvette Exp Post 4.2 30.5 12.8
25 3 10C5 Cuvette Exp ^ 12.1 55.9 67.6
26 3 20C10 Cuvette Exp ^ 7.3 63.5 46.4
27 3 40C10 Cuvette Exp ^ 4.8 43.5 20.9
28 3 10C5 Cuvette Exp Post 9.4 37.5 35.3
29 3 20C10 Cuvette Exp Post 8.4 44.3 37.2
30 3 40C10 Cuvette Exp Post 7.4 27.8 20.6
PC-3 cells were subjected to 1 or 3 standardised exponential pulses of 200 V/25 WF/800 6 (Exp) or a square pulse (Sq) of 125^500 V/
cm and 5^30 Ws duration with or without a prior DC charge (a) in 0.3 M sucrose with/out polyethylene glycol (b). Centrifugation was
performed prior to or immediately post pulse delivery (c). PEG concentration in some conditions (C) was diluted immediately post
pulse to induce cell dilation. Similar results were obtained in two separate experiments.
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sucrose medium improved hybrid formation. The ef-
fect was improved with increasing PEG concentra-
tion from 10 to 40% (conditions 18, 20, 21). When
used in combination with DC current, 10% PEG
induced high levels of cell fusion. Heating of PEG-
containing medium reduced the cell survival and the
overall hybrid yield. Neither the proportion of fusion
nor the cell survival were augmented by PEG and
subsequent centrifugation (conditions 22^24). The
aggregation of cells caused by sudden dilution of
PEG to twice the original volume with sucrose solu-
tion also induced cell fusion (conditions 25^27), par-
ticularly with an initial 10% PEG solution, and this
treatment yielded one of the highest totals of hybrid
cells. Recovery of cells from experiments with diluted
PEG was much reduced by combination with centri-
fugation (conditions 28^30).
3.5. Cross-matching of human cells
Cells of the same or di¡erent lineages were pulsed
in a 1:1 ratio under the conditions of 60 VDC/200 V/
25 WFd/800 6 per 4 mm cuvette (Table 3). Most cells
have a characteristic capacity to form hybrids under
these conditions with the proportion of dual-£uores-
cent hybrids varying less than 1 or 2% in repeated
tests when healthy cells in mid-growth phase are
used. The fusion e⁄ciency of formation of mixed
hybrids between cells of di¡erent lineage appears to
be similar to the fusion rate obtained with homolo-
gous cells. The enumeration of hybrids by FACS
evaluated hybrids of mixed cell type. The microscop-
ic evaluation of fused suspension and adherent cell
lines yielded approximately equal numbers of hybrid
cells exhibiting red or green £uorescence and those
showing red and green £uorescence (data not
shown). The capacity for fusion of di¡erent suspen-
sion cell lines was found particularly variable, with
the fusogenic cell line H9 performing better than
most adherent lines. The survival rate of all suspen-
sion cell lines under these bu¡er conditions was ap-
proximately half or less of those of adherent cells,
with 30% recovery or less of suspension cells after
exposure to the pulse and harvesting.
3.6. Fusion with dendritic cells
MCF-7 and LNCaP cells mixed in 1:1 ratio with
fresh dendritic cells were treated with DC current
and pulsed with charges of similar parameters as
previously used for these cell lines (Fig. 4). Dendritic
cells proved highly amenable to fusion with the cell
lines investigated. Hybrids with dendritic cells were
formed in similar proportion to homologous MCF-7
and LNCaP cell fusions (Fig. 3). Generally, the op-
timal parameters of the pulse were very close to those
found successful with the cell line to itself in each
case. Dendritic cell hybrids yield with either MCF-7
or LNCaP cells did not improve with variations with
in resistance (6) of the pulse, unlike the homologous
cell fusions.
3.7. Puri¢cation and culture of hybrid cells
Unfused cells from experiments involving CD34+
cells pulsed with a variety of tumour cell lines were
eliminated as separate bands in standard density gra-
dients. Hybrid cells formed a di¡use lower band with
90^95% dual £uorescence by FACS analysis. Re-
peated density gradient centrifugation reduced, but
did not eliminate, cells with only a single stain de-
tectable by FACS. The proportion of the hybrid cells
which attached to culture £asks was at least 50% of
the proportion of total live cells. Plated cells initially
grew slowly with a high proportion of the dual
stained progeny cells not attaching to the culture
plates. Further density gradient puri¢cation was nec-
Table 3
Fusion of homologous and non-homologous cells
Cell/cell % Hybrids % Survival Hybrid yield
(U103)
293/293 16.7 73.2 122.2
PC-3/PC-3 14.1 67.5 95.2
K-562/K-562 3.6 30.6 11.0
H9/H9 19.6 25.8 50.6
PC-3/293 14.9 65.8 98.1
PC-3/K-562 8.9 52.2 46.5
293/K562 9.2 55.5 51.1
PC-3/H9 16.1 46.4 74.7
H9/K562 13.5 31.8 42.9
1U106 cells were charged in a 1:1 ratio under standardised
electrical conditions of 60 VDC/200 V/25 WFd/800 6 per 4 mm
waxed cuvette. Viable cells were counted with trypan blue and
the % of dual £uorescent hybrids was determined by FACS
analysis.
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Fig. 4. Tumour/dendritic cell hybrids. The proportion of dual £uorescent hybrids of dendritic cell fused with LNCaP and MCF-7
cells, under di¡erent electrical conditions in a waxed cuvette, is shown in the upper right quadrant.
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essary to prevent the overgrowth of the culture with
single tumour cells. In each experiment, however, a
stable population of dual stained cells was estab-
lished in culture.
4. Discussion
We have investigated a variety of electrofusion
strategies and established optimised electrofusion pa-
rameters for simple and reproducible creation of
large numbers of dendritic cell/tumour cell hybrids
for use as an anti-tumour vaccine. Hybrids in quan-
tities that are being shown to be e⁄cacious in human
clinical trials [30^33] can be attained with minor am-
pli¢cation. Standard density gradient centrifugation
enabled puri¢cation of hybrid cells and establishment
of a stable population of hybrid cells with increasing
plating e⁄ciency and progressive doubling time. The
possibility of culture of therapeutic quantities of hy-
brid cells rapidly could allow immunotherapeutic
intervention with a vaccine of autologous tumour
antigen-presenting cells before signi¢cant disease
progression. In murine models, syngeneic tumour
cells fused with antigen-presenting cells are protective
of a variety of malignancies [13^15]. An initial helper
T-cell and a speci¢c cytotoxic T-cell response were
demonstrated in the protection of hybrid cell vacci-
nated mice to lymphoma [15]. E⁄cient fusion and
further culture ampli¢cation will provide su⁄cient
autologous hybrid cells with the requisite individual
immunological speci¢city for human anti-tumour
vaccination. The release of cells from solid tumours
for fusion with dendritic cells could extend the appli-
cation of hybrid cell vaccines to many malignancies.
The majority of previous studies of cell fusion
have utilised antibodies to surface glycoproteins
[34] or membrane dyes [28,35] for staining of cells
prior to electrofusion. Membrane fragmentation
and amalgamation are common e¡ects of electric
pulses to cells [36] and are well known to distort
estimations of cell fusion [37,38]. Li et al. [28], for
example, estimated a rate of fusion of 60^80% by
membrane mixing but formation of hybrids was be-
low 1%. The considerable disruption of cells inherent
in the electrofusion process and the transfer of mem-
brane fragments between cells makes surface staining
a £awed method of assessing the proportion of hy-
brid cells. These experiments utilised £uorescent
chloromethyl dyes which di¡use through the mem-
branes of live cells, undergo a cytoplasmic gluta-
thione S-transferase-mediated reaction and are re-
tained in the cell [26]. A shift in cell refractivity
caused by the pulse, observed when cells were pulsed
immediately after staining, was lost at a rate that
varied with di¡erent cell lines. In speci¢c tests, how-
ever, there was no transfer of dye between stained
cells of any type. The low proportion of dual-£uo-
rescent events detected by FACS after incubation
without pulsing, equivalent to background positive
level in control fusion panels, were observed by £uo-
rescent microscopy as aggregates of individually
stained cells and could be controlled by careful trit-
uration. Cell recovery was elevated in experiments
done without staining of cells and it is evident that
while dye staining represents a reliable method for
detection of mixed cell hybrids [26] it contributes
considerably to cell mortality.
Electrofusion is commonly held to be a stepwise
process, requiring a preliminary procedure to bring
cells into alignment or close proximity prior to deliv-
ery of a DC pulse in which cell membranes are mo-
mentarily destabilised and fuse to form hybrid cells
[26,29]. Study of the behaviour of cells in electrical
¢elds has shown that transient membrane break-
down, allowing spontaneous and rapid resealing, oc-
curs when short duration, high intensity electrical
impulses of direct current are applied across the
cell membrane [29,39]. When impulses are greater
than 2 kV/cm or exceed 100 Ws duration membrane
breakdown is irreversible. A range of techniques
have been employed as the preliminary step prior
to pulse delivery. Both sonic and magnetic ¢elds
can propel cells into contact prior to a pulse
[40,41]. Cells can be forced into close contact by
centrifugation and fused together in a pellet [35,38]
or fused when in contact as a con£uent monolayer
[42]. Likewise, a variety of chemical bridges have
been used to improve the proportion of monoclonal
antibody hybridomas [43,44] and polymeric chemi-
cals have been used to induce cell aggregation with
electrofusion [45,46].
Membrane fusion can also be induced without any
physical or chemical treatment of the cells. Teissie et
al. [42] were able to form hybrid cells, evaluated at
5^10% with more than one nucleus, by simple appli-
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cation of ¢ve or more pulses of between 1 and 2 kV/
cm to cell monolayers on plastic culture plates. Sim-
ilar fusion rates have been achieved between di¡erent
adherent cells [40,48] and indicates that physical con-
tact is su⁄cient to induce the fusion of cell mem-
branes under conditions that cause the reversible
breakdown of membrane integrity. On the other
hand, the lower fusion rate achieved with most sus-
pension cells may in part be due to the prior trypsi-
nisation of adherent cell lines, since protease treat-
ment reduces the intracellular spacing and the
aqueous boundary between erythrocyte ghosts and
improves the fusion rate [49,50].
The best studied electrofusion process, named di-
electrophoresis, aligns cells closely by means of di-
poles generated in an alternating current ¢eld with
fusion triggered by a series of high intensity DC
pulses [29]. It is argued that, as ¢eld strength is great-
est along the axis of the applied current, aligning the
cells with alternating current will serve to orient the
sites of membrane breakdown and contribute to fu-
sion [34]. It is possible that in conditions of high cell
density the cells themselves may represent the elec-
trical pathway of least resistance and the formation
of pearl chains between the electrodes will be induced
and contribute to fusion. We could not reproduce
pearl chain formation in a cuvette and observed in-
stead the alignment of cells midway between electro-
des under alternating current, perpendicular to the
electrical axis. Generally, this method has been ap-
plied to the production of antibody hybridomas and
the addition to the fusion rate has not been critically
evaluated. The propensity of dielectrophoresis to fuse
cells of similar size, selecting activated lymphocytes
for fusion to the larger murine myeloma cells [51],
may partially account for the higher output of pro-
ductive hybridomas. Preliminary alignment of cells in
alternating current in the cuvette did not signi¢cantly
augment the fusion rate. By contrast, it was found
that the application of a direct current to the cells
prior to pulse delivery forced the cells in close juxta-
position on the positive electrode of the cuvette and
contributed to cell fusion. A signi¢cant fusion rate
was only observed in conjunction with a wax cover-
ing to one electrode. This insulation layer, by limit-
ing current £ow to a critical point, could reduce det-
rimental Joule heating and allow the build-up of an
electrostatic ¢eld, polarising the electrodes and there-
by inducing the critical aggregation of cells on the
anode.
The most critical parameters in electrofusion af-
fecting hybrid cell yield were the strength and dura-
tion of the electrical pulse. In agreement with others
[39,52], we observed these parameters to be inversely
related. A pulse of shorter time can be compensated
by increasing the conductivity of the medium or
chamber or increasing the pulse ¢eld strength to
achieve an equivalent level of fusion. For a particular
electrical charge, however, a set pulse duration of
between 15 and 20 ms was optimal for yield of hy-
brid cells. The DC current and the pulse charge were
also roughly reciprocal in overall yield of hybrid
cells, the improvement in the fusion rate with higher
values of DC current or pulse charge being counter-
balanced by accruing cell mortality. The proportion
of fused cells of di¡erent cell lines varied with each
modulation of the DC current and charge, capaci-
tance and resistance parameters of the Gene Pulser.
The optimal set of electrical parameters yielding the
greatest number of hybrid cells could be reproducibly
de¢ned, but varied considerably for each cell line
studied. The highest level of hybrid formation was
characteristic of each cell line with some cells in this
study, such as H9 cells, being intrinsically more fu-
sogenic than others. De¢nition of best electrofusion
parameters for a new cell line, therefore, needs to be
performed across a wide range of electrical condi-
tions in the ¢rst instance. The indications that low
and high variations in resistance of the cell adversely
a¡ect fusion with dendritic cells could simplify pro-
spective investigations of the optimised electrical pa-
rameters for patient tumour cell and dendritic cell
fusions to amplitude of the charge (V) of the pulse
and DC charge.
The combination of DC alignment and DC pulse
was the preferred means of hybrid formation
although alternative methods using centrifugation
or causing cell aggregation by dilution of a PEG-
containing medium gave equivalent or greater yield
of hybrids. The relatively simple means of optimising
the two electrical parameters to suit each new cell
line were advantageous. The commonly used chem-
ical fusogen PEG, causing hygroscopic aggregation
and shrinkage of cells, mimics other physical meth-
ods to bring cells into contact. The fusion rate of
cells pulsed in PEG-containing medium, in contrast
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with previous results with CHO cells [53], increased
with the concentration of PEG. Fusion in PEG also
improved with concurrent alignment by DC charge,
but cell survival was overwhelmingly a¡ected by
combining PEG incubation with either DC align-
ment or centrifugation. It is the removal of PEG
after incubation of B-cells and myeloma cells that
is thought to initiate fusion through cell swelling
[54,55]. Thus, dilution of the PEG concentration in
the cuvette immediately after the pulse brought
about a large increase in fusion.
The higher fusion rate achieved by centrifugation
after the pulse rather than before, as seen with PC-3
cells, may contradict the premise that cells need to be
in contact or close proximity at the time the pulse is
delivered [26,29]. The resealing time for membrane
bilayers disrupted by electrical pulses is very rapid
[56], but there is a component of electropermeabi-
lised cells that persists for extended periods. Tiessie
and Rols [57] observed that a high intensity pulse of
800^1600 V/cm created a long-lasting condition of
permeability which gradually disappeared over 40
min. A higher fusion rate obtained by centrifugation
subsequent to the pulse has been observed before
[57,58] and indicates that forcing cell contact before
applying the pulse is not the only way to generate
electrofusion.
Hybrid cells puri¢ed from fused human tumour
and CD34+ cells gradually assumed an e⁄cient
growth pattern in culture. Attempts to establish cul-
tures of hybrid cells with dendritic cells matured with
cytokines from peripheral blood monocytes [59,60]
were unsuccessful and it could be that the added
replicative potential of early progenitor cells is re-
quired to form stable hybrid populations. Syngeneic
hybrid cells have been shown to be immunologically
protective in murine malignancies. The high levels of
electrofusion demonstrated with a variety of strat-
egies in this report and the subsequent culture of
fused cells overcomes many of the technical obstacles
to generating su⁄cient autologous hybrid cells with
individual speci¢city for human anti-cancer vaccina-
tion.
Acknowledgements
This work was supported by the Cancer Vaccine
Campaign of the St George’s Hospital Special Trust-
ees.
References
[1] D.M. Pardoll, Cancer vaccines, Immunol. Today 14 (1993)
310^316.
[2] A.N. Houghton, Cancer antigens: immune recognition of
self and altered self, J. Exp. Med. 180 (1994) 1^4.
[3] T. Boon, P. van der Bruggen, Human tumour antigen rec-
ognised by T lymphocytes, J. Exp. Med. 183 (1996) 725^
729.
[4] B.E. Elliot, D.A. Carlow, A.M. Rodricks, A. Wade, Perspec-
tives on the role of MHC antigens in normal and malignant
cell development, Adv. Cancer Res. 53 (1989) 181^245.
[5] F. Ruiz-Cabello, E. Klein, F. Garrido, MHC antigens on
human tumours, Immunol. Lett. 29 (1991) 181^189.
[6] F.V. Cromme, J. Airey, M.T. Heemels, H.L. Ploegh, P.J.
Keating, P.L. Stern, C.J. Meijer, J.M. Walboomers, Loss
of transporter protein, encoded by the TAP-1 gene, is highly
correlated with loss of HLA expression in cervical carcino-
mas, J. Exp. Med. 179 (1994) 335^340.
[7] M.J. Maeurer, S.M. Colin, D. Martin, W. Swaney, J. Bry-
ant, C. Castelli, P. Robbins, G. Parmiani, W.J. Storkus,
M.T. Lotze, Tumour escape from immune recognition: le-
thal recurrent melanoma on a patient associated with down-
regulation of the peptide transporter protein TAP-1 and the
loss of the immunodominant MART-1/Melan-A antigen, J.
Clin. Invest. 98 (1996) 1633^1641.
[8] B. Seliger, M.J. Maeurer, S. Ferrone, TAP o¡^Tumour on,
Immunol. Today 18 (1997) 292^299.
[9] L. Chen, S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom,
J.A. Ledbetter, P. McGowan, P.S. Linsley, Costimulation of
antitumor immunity by the B7 counterreceptor for the T
lymphocye molecules CD28 and CTLA-4, Cell 71 (1992)
1093^1102.
[10] S.E. Townsend, J.P. Allison, Tumor rejection after direct
stimulation of CD8+ T cells by B7-transfected melanoma
cells, Science 259 (1993) 368^370.
[11] N.P. Restifo, F. Esquivel, Y. Kawakami, J.W. Yewdell, J.J.
Mule, S.A. Rosenburg, J.R. Bennink, Identi¢cation of hu-
man cancers de¢cient in antigen processing, J. Exp. Med.
177 (1993) 265^272.
[12] M.G. Sanda, N.P. Restifo, J.C. Walsh, Y. Kawakami, W.G.
Nelson, D.M. Pardoll, J.W. Simons, Molecular characteriza-
tion of defective antigen presentation in human prostate
cancer, J. Natl. Cancer Inst. 87 (1995) 241^243.
[13] J. Gong, D. Chen, M. Kashiwaba, D. Kufe, Induction of
antitumor activity by immunization with fusions of dendritic
and carinoma cells, Nat. Med. 3 (1997) 558^561.
[14] Y. Guo, M. Wu, H. Chen, X. Wang, G. Liu, G. Li, J. Ma,
M-S. Sy, E¡ective tumour vaccine generated by fusion of
hepatoma cells with activated B cells, Science 263 (1994)
518^520.
BBADIS 61908 16-2-00
T.H. Scott-Taylor et al. / Biochimica et Biophysica Acta 1500 (2000) 265^279 277
[15] G. Stuhler, U. Trefzer, P. Walden, Hybrid cell vaccination in
cancer immunotherapy. Recruitment and activation of T cell
help for induction of anti tumour cytotoxic T cells, Adv.
Exp. Med. Biol. 451 (1998) 277^282.
[16] R.M. Steinman, Dendritic cells and immune-based therapies,
Exp. Hematol. 24 (1996) 859^862.
[17] K. Inaba, J.P. Metlay, M.T. Crowley, R.M. Steinman, Den-
dritic cells pulsed with protein antigens in vitro can prime
antigen-speci¢c, MHC-restricted T cells in situ, J. Exp. Med.
172 (1990) 631^640.
[18] J.W. Young, K. Inaba, Dendritic cells as adjuvants for class
I major histocompatibility complex-restricted antitumor im-
munity, J. Exp. Med. 183 (1996) 7^11.
[19] S. Grabbe, S. Beissert, T. Schwarz, R.D. Granstein, Den-
dritic cells as initiators of tumour immune responses: a pos-
sible strategy for tumor immunotherapy?, Immunol. Today
16 (1995) 117^121.
[20] A. Lanzavecchia, Identifying strategies for immune interven-
tion, Science 260 (1993) 937^944.
[21] S.K. Nair, D. Boczkowski, M. Morse, R.I. Cumming, H.K.
Lyerly, E. Gilboa, Induction of primary carcinoembyronic
antigen (CEA)-speci¢c cytotoxic T lymphocytes in vitro us-
ing human dendritic cells transfected with RNA, Nat. Bio-
technol. 16 (1998) 364^369.
[22] C.M. Celluzzi, L.D. Falo, Epidermal dendritic cells induce
potent antigen-speci¢c CTL-mediated immunity, J. Invest.
Dermatol. 108 (1997) 716^720.
[23] W. Song, H.L. Kong, H. Carpenter, H. Torii, R. Granstein,
S. Ra¢i, M.A. Moore, R.G. Crystal, Dendritic cells genet-
ically modi¢ed with an adenovirus vector encoding the
cDNA for a model antigen induce protective and therapeutic
antitumor immunity, J. Exp. Med. 186 (1997) 1247^1256.
[24] M. De Veerman, C. Heirman, S. Van Meirvenne, S. Devos,
J. Corthlas, M. Moser, K. Theilmans, Retrovirally trans-
duced bone-marrow derived dendritic cells require CD4+ T
cell help to elicit protective and therapeutic antitumor im-
munity, J. Immunol. 162 (1999) 144^151.
[25] G. Kohler, C. Milstein, Derivation of speci¢c antibody-pro-
ducing tissue culture and tumor lines by cell fusion, Eur.
J. Immunol. 6 (1976) 511^519.
[26] M.J. Jaroszeski, R. Gilbert, P.G. Fallon, R. Heller, Mechan-
ically facilitated cell^cell electrofusion, Biophys. J. 67 (1994)
1574^1581.
[27] M.J. Jaroszeski, R. Heller, R. Gilbert, Detection and quan-
titation of cell-electrofusion products by £ow cytometry,
Anal. Biochem. 216 (1994) 271^275.
[28] L.H. Li, M.L. Henson, Y.L. Zhao, S.W. Hui, Electrofusion
between heterogenous-sized mammalian cells in a pellet : po-
tential applications in drug delivery and hybridoma forma-
tion, Biophys. J. 71 (1996) 479^486.
[29] U. Zimmerman, Electric ¢eld-mediated fusion and related
electrical phenomena, Biochim. Biophys. Acta 694 (1982)
227^277.
[30] G. Murphy, B. Tjoa, H. Ragde, G. Kenny, A. Boynton,
Phase I clinical trial T cell therapy for prostate cancer using
autologous dendritic cells pulsed with HLA-A201-speci¢c
peptides from prostate speci¢c membrane antigen, Prostate
29 (1996) 371^380.
[31] M.T. Lotze, B. Hellerstedt, L. Stolinski, T. Tueting, C. Wil-
son, D. Kinzler, H. Vu, J.T. Rubin, W. Storkus, H. Tahara,
E. Elder, T. Whiteside, The role of interleukin-2, interleukin-
12, and dendritic cells in cancer therapy, Cancer J. Sci. Am.
3 (1997) S109^114.
[32] M.L. Salgaller, B.A. Tjoa, P.A. Lodge, H. Ragde, G. Kenny,
A. Boynton, G.P. Murphy, Dendritic cell-based immuno-
therapy of prostate cancer, Crit. Rev. Immunol. 18 (1998)
109^119.
[33] B.A. Tjoa, S.L. Erikson, V.A. Bowes, H. Ragde, G.M.
Kenny, O.E. Cobb, R.C. Ireton, M.J. Troychak, A.I. Boyn-
ton, G.P. Murphy, Follow-up evaluation of prostate cancer
patients infused with autologous dendritic cells pulsed with
PSMA peptides, Prostate 32 (1997) 272^278.
[34] G.A. Neil, U. Zimmermann, Electrofusion, Methods Enzy-
mol. 220 (1993) 174^246.
[35] I.G. Abidor, A.E. Sowers, Kinetics and mechanism of cell
membrane electrofusion, Biophys. J. 61 (1992) 1557^
1569.
[36] J.W. Wojcieszyn, R.A. Schlegel, K. Lumley-Sapanski, K.A.
Jakobson, Studies on the mechanism of polyethylene glyco-
induced cell fusion using £uorescent and cytoplasmic probes,
J. Cell Biol. 96 (1983) 151^159.
[37] A.E. Sowers, Characterization of electric ¢eld-induced fusion
of erythrocyte ghost membranes, J. Cell Biol. 99 (1988)
1989^1996.
[38] L.Y. Song, Q.F. Ahkong, J.M. Baldwin, R. O’Reilly, J.A.
Lucy, Divalent cations, phospholipid asymmetry and os-
motic swelling in electrically-induced lysis, cell fusion and
giant cell formation with human erythrocytes, Biochim. Bio-
phys. Acta 1148 (1993) 30^38.
[39] A.E. Sowers, The study of membrane fusion and electropo-
ration mechanisms. In: M.J. Allem, S.F. Cleary, F.M.
Hawkridge (Eds.), Charge and Field E¡ects in Biosystems,
Vol. 2, Plenum Press, New York, 1989, pp. 315^337.
[40] I. Kramer, K. Vienken, J. Vienken, U. Zimmermann, Mag-
neto-electro-fusion of human erythrocytes, Biochim. Bio-
phys. Acta 772 (1984) 407^410.
[41] U. Bertsche, A. Mader, U. Zimmermann, Nuclear mem-
brane fusion in electrofused mammalian cells, Biochim. Bio-
phys. Acta 939 (1988) 509^522.
[42] J. Teissie, V.P. Knutson, T.Y. Tsong, M.D. Lane, Electrical
pulse-induced fusion of 3T3 cells in monolayer culture, Sci-
ence 216 (1982) 537^538.
[43] M.M.S. Lo, T.Y. Tsong, M.K. Conrad, S.M. Strittmatter,
L.D. Hester, S.H. Snyder, Monoclonal antibody production
by receptor-mediated electrically induced cell fusion, Nature
310 (1984) 792^794.
[44] D.M. Wojchowski, A.J. Sytkowski, Hybridoma production
by simpli¢ed avidin-mediated electrofusion, J. Immunol.
Methods 90 (1986) 173^177.
[45] N.G. Stoicheva, S.W. Hui, Electrically induced fusion of
mammalian cells in the presence of polyethylene glycol,
Membrane Biol. 140 (1994) 177^182.
BBADIS 61908 16-2-00
T.H. Scott-Taylor et al. / Biochimica et Biophysica Acta 1500 (2000) 265^279278
[46] L.H. Li, S.W. Hui, Characterization of PEG-mediated elec-
trofusion of human erythrocytes, Biophysical J. 67 (1994)
2361^2366.
[47] C. Finaz, A. Lefevre, J. Teissie, A new, highly e⁄cient tech-
nique for generating somatic cell hybrids, Biochim. Biophys.
Acta 1023 (1984) 389^397.
[48] S.I. Sukharev, I.N. Bandrina, A.I. Barbul, L.I. Fedorova,
I.G. Abidor, A.V. Zelenin, Electrofusion of ¢broblasts on
the porous membrane, Biochim. Biophys. Acta 1034 (1990)
125^131.
[49] T. Ohno-Shosaku, Y. Okada, Facilitation of electrofusion of
mouse lymphoma cells by the proteolytic action of proteases,
Biochem. Biophys. Res. Commun. 120 (1984) 138^143.
[50] D.A. Stenger, S.W. Hui, Kinetics of ultrastructure changes
during electrically induced fusion of human erythrocytes,
J. Membr. Biol. 93 (1986) 43^53.
[51] J.J. Schmitt, U. Zimmermann, G.A. Niel, E⁄cient genera-
tion of stable antibody forming hybridoma cells by electro-
fusion, Hybridoma 8 (1989) 107^115.
[52] D.V. Zhelev, D.S. Dimitrov, P. Dionov, Correlation between
physical parameters in electrofusion and electroporation of
protoplasts, Bioelectrochem. Bioenerg. 20 (1988) 155^167.
[53] Stoicheva and Hui (1994).
[54] J.M. Robinson, D.S. Roos, R.L. Davidson, M.J. Karnov-
sky, Membrane alterations and other morphological features
observed with polyethylene glycol-induced cell fusion, J. Cell
Sci. 40 (1979) 63^75.
[55] S.W. Hui, T. Isac, L.T. Boni, A. Sen, Action of polyethylene
glycol on the fusion of human erythrocyte membranes,
J. Membr. Biol. 84 (1985) 137^146.
[56] R. Benz, U. Zimmermann, The resealing process of lipid
bilayers after reversible electrical breakdown, Biochim. Bio-
phys. Acta 640 (1981) 169^178.
[57] J. Tiessie, M.P. Rols, Fusion of mammalian cells in culture is
obtained by creating the contact between cells after their
electropermeabilization, Biochem. Biophys. Res. Commun.
140 (1986) 258^266.
[58] A.E. Sowers, A long-lived fusogenic state is induced in eryth-
rocyte ghosts by electric pulses, J. Cell Biol. 102 (1986) 1358^
1362.
[59] N. Romani, D. Reider, M. Heuer, E. Kampgen, B. Eibl, D.
Niederwieser, G. Schuler, Generation of mature dendritic
cells from human blood. An improved method with special
regard to clinical applicability, J. Immunol. Methods 196
(1996) 137^145.
[60] L-J. Zhou, T.F. Tedder, CD14+ blood monocytes can di¡er-
entiate into functionally mature CD83+ dendritic cells, Proc.
Natl. Acad. Sci. USA 93 (1996) 2588^2594.
BBADIS 61908 16-2-00
T.H. Scott-Taylor et al. / Biochimica et Biophysica Acta 1500 (2000) 265^279 279
